17 May 2007

Statement from the ITF regarding drug-testing at 2007 Roland Garros

News Article

The ITF, in accordance with the WADA Code and the Tennis Anti-Doping Programme, uses a WADA-accredited laboratory to analyse all samples. The ITF uses the Laboratoire de contrôle du dopage INRS – Institut Armand-Frappier in Montreal, and is satisfied with the service it receives.

The Montreal laboratory – as for all WADA-accredited laboratories – works in accordance with the WADA International Standard for Laboratories, and so with all other factors being effectively equal, the ITF elected to use the Montreal Laboratory primarily on the basis of cost.

The cost of an analysis at Montreal is US$170, whereas the cost of analysis at le Laboratoire National de Depistage du Dopage (LNDD) de Chatenay Malabry is €277 (US$376 at current exchange rates), more than double that of Montreal. The ITF offered an opportunity to the LNDD to improve its offer. The result was an offer of a reduction of 30 per cent in LNDD costs. This still left the cost of analysis at LNDD at US$263 per test, US$93 per test more than Montreal.

The saving that the ITF has made in moving to Montreal has permitted more tests to be conducted. Testing at Roland Garros will increase from 149 urine tests in 2006 to 180 in 2007. In addition, EPO urine tests will be increased from three to 20. Blood testing is scheduled to be the same as in 2006.

The savings made from moving the testing from the LNDD to Montreal have been reinvested in anti-doping to make the anti-doping programme at Roland Garros more efficient and effective than ever before.

The testing of the samples by Montreal will have no degradation impacts and there will be no delays. For queries regarding the Montreal laboratory please contact:

Laboratoire de contrôle du dopage
INRS - Institut Armand-Frappier
245, boulevard Hymus
Québec, H9R 1G6

Tel: (1.514) 630 88 06
Fax: (1.514) 630 89 99